Our Company

1 of 1
1-2 of 2
What’s in the Part D Payment Modernization Model Request for Application: More questions than answers08 March 2019 - By Nicholas Johnson and Tracy A. Margiott and Matthew Hayes and Adam Barnhart - Article

With less than one month to respond, many details unknown, and multiple impending changes to the Part D program, the Part D Payment Modernization Model’s Request for Applications leaves more questions than answers.

An end to manufacturer rebates as we know them today?15 February 2019 - By Deana Bell and Jennifer Carioto and Matthew Hayes - Article

The proposed rule to make drug manufacturer rebates no longer protected under the Anti-Kickback Statute has broad impacts to federally funded prescription drug programs, especially Medicare Part D.

1 of 1

  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman